Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoglycemia | 1 | 2017 | 24 | 0.530 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 101 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 181 | 0.460 |
Why?
|
| Blood Glucose | 1 | 2017 | 386 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 744 | 0.300 |
Why?
|
| Endosonography | 1 | 2017 | 6 | 0.130 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 9 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2017 | 8 | 0.130 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 112 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2017 | 305 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 51 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 288 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2017 | 154 | 0.120 |
Why?
|
| Needles | 1 | 2016 | 11 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1111 | 0.120 |
Why?
|
| Religion | 1 | 2014 | 90 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1582 | 0.100 |
Why?
|
| Health Behavior | 1 | 2014 | 568 | 0.080 |
Why?
|
| Health Promotion | 1 | 2014 | 691 | 0.070 |
Why?
|
| Aged | 2 | 2017 | 7958 | 0.070 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 11 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 728 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4928 | 0.060 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.060 |
Why?
|
| Adolescent | 1 | 2017 | 5949 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 106 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 93 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2007 | 128 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 133 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2007 | 348 | 0.060 |
Why?
|
| Middle Aged | 2 | 2017 | 11790 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2006 | 633 | 0.050 |
Why?
|
| Male | 3 | 2017 | 22745 | 0.040 |
Why?
|
| Humans | 5 | 2017 | 42113 | 0.040 |
Why?
|
| Adult | 1 | 2017 | 13437 | 0.040 |
Why?
|
| Female | 2 | 2017 | 23980 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1246 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1068 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2016 | 29 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 27 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 357 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cell Survival | 2 | 2007 | 934 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 1570 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 256 | 0.020 |
Why?
|
| Life Style | 1 | 2014 | 326 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 370 | 0.020 |
Why?
|
| Social Support | 1 | 2014 | 437 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1135 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1019 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 336 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1004 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 658 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2014 | 461 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1221 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 674 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 810 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2790 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2007 | 45 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 2006 | 13 | 0.020 |
Why?
|
| Carcinogens | 1 | 2007 | 126 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 51 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2006 | 43 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2006 | 28 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2006 | 93 | 0.020 |
Why?
|
| Neurites | 1 | 2006 | 40 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 58 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 277 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2006 | 151 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 131 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 574 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 458 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 884 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1076 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2598 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 3701 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 16694 | 0.000 |
Why?
|